Acumen Pharmaceuticals Inc (ABOS) Historical Volatility

Tracking ABOS historical volatility helps you see how much Acumen Pharmaceuticals Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Acumen Pharmaceuticals Inc's HV tells you what really happened. Use our scanner to monitor ABOS 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The ABOS 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Acumen Pharmaceuticals Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Acumen Pharmaceuticals Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where ABOS HV is running hot, cold, or in line. Make the ABOS 30 day historical volatility — and every other window — work for your edge instead of against it.